U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07138261) titled 'Taiwanese Anaplastic Thyroid Cancer Registry' on Aug. 03.
Brief Summary: Primary treatment strategies for ATC have included surgical resection combined with radiotherapy, chemotherapy, or concurrent chemoradiation therapy. Despite these aggressive approaches, disease recurrence or progression remains frequently observed. Recent advances in molecular diagnostics and targeted therapy development have expanded treatment options for ATC patients with actionable genetic alterations, such as BRAF mutations or NTRK fusions. Nevertheless, for patients lacking identifiable targetable mutations, therapeutic options remain limited and clinical...